{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T13:43:11Z","timestamp":1775742191939,"version":"3.50.1"},"reference-count":36,"publisher":"The Fukushima Society of Medical Science","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Fukushima J. Med. Sci.","FJMS"],"published-print":{"date-parts":[[2012]]},"DOI":"10.5387\/fms.58.107","type":"journal-article","created":{"date-parts":[[2012,12,13]],"date-time":"2012-12-13T22:43:16Z","timestamp":1355438596000},"page":"107-116","source":"Crossref","is-referenced-by-count":28,"title":["AUTOANTIBODIES BY LINE IMMUNOASSAY IN PATIENTS WITH PRIMARY BILIARY CIRRHOSIS"],"prefix":"10.5387","volume":"58","author":[{"given":"HIRONOBU","family":"SAITO","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ATSUSHI","family":"TAKAHASHI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KAZUMICHI","family":"ABE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KEN","family":"OKAI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"FUMIKO","family":"KATSUSHIMA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KYOKO","family":"MONOE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YUKIKO","family":"KANNO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HIROMASA","family":"OHIRA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3342","reference":[{"key":"1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra043898"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Hu CJ, Zhang FC, Li YZ, Zhang X. Primary biliary cirrhosis: what do autoantibodies tell us? World J Gastroenterol, <b>16<\/b>: 3616-3629, 2010.","DOI":"10.3748\/wjg.v16.i29.3616"},{"key":"3"},{"key":"4","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21472"},{"key":"5","unstructured":"5. Lacerda MA, Ludwig J, Dickson ER, Jorgensen RA, Lindor KD. Antimitochondrial antibody-negative primary biliary cirrhosis. Am J Gastroenterol, <b>90<\/b>: 247-249, 1995."},{"key":"6","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510250507"},{"key":"7","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510280203"},{"key":"8","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510290409"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Heathcote E. Primary Biliary Cirrhosis. <i>In<\/i>: Schiff E, Sorrell M, Maddrey W, eds. Diseases of the Liver. Lippincott Williams &amp; Wilkins, Philadelphia, 701-712, 2003.","DOI":"10.1016\/S1089-3261(03)00106-5"},{"key":"10","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(99)80297-9"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Scheuer P. Primary biliary cirrhosis. Proc R Soc Med, <b>60<\/b>: 1257-1260, 1967.","DOI":"10.1177\/003591576706001205"},{"key":"12","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.12.029"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Gershwin ME, Mackay IR, Sturgess A, Coppel RL. Identification and specificity of a cDNA encoding the 70 kd mitochondrial antigen recognized in primary biliary cirrhosis. J Immunol, <b>138<\/b>: 3525-3531, 1987.","DOI":"10.4049\/jimmunol.138.10.3525"},{"key":"14","doi-asserted-by":"crossref","unstructured":"15. Kadokawa Y, Omagari K, Hazama H, Ohba K, Masuda J, Kinoshita H, Hayashida K, Isomoto H, Mizuta Y, Murase K, Murata I, Kohno S. Evaluation of newly developed ELISA using &ldquo;MESACUP-2 test mitochondrial M2&rdquo; kit for the diagnosis of primary biliary cirrhosis. Clin Biochem, <b>36<\/b>: 203-210, 2003.","DOI":"10.1016\/S0009-9120(02)00439-3"},{"key":"15","doi-asserted-by":"crossref","unstructured":"16. Stinton LM, Swain M, Myers RP, Shaheen AA, Fritzler MJ. Autoantibodies to GW bodies and other autoantigens in primary biliary cirrhosis. Clin Exp Immunol, <b>163<\/b>: 147-156, 2011.","DOI":"10.1111\/j.1365-2249.2010.04288.x"},{"key":"16","doi-asserted-by":"crossref","unstructured":"17. Milkiewicz P, Buwaneswaran H, Coltescu C, Shums Z, Norman GL, Heathcote EJ. Value of autoantibody analysis in the differential diagnosis of chronic cholestatic liver disease. Clin Gastroenterol Hepatol, <b>7<\/b>: 1355-1360, 2009.","DOI":"10.1016\/j.cgh.2009.07.012"},{"key":"17","doi-asserted-by":"crossref","unstructured":"19. Worman HJ, Courvalin JC. Antinuclear antibodies specific for primary biliary cirrhosis. Autoimmun Rev, <b>2<\/b>: 211-217, 2003.","DOI":"10.1016\/S1568-9972(03)00013-2"},{"key":"18","doi-asserted-by":"crossref","unstructured":"20. Wichmann I, Montes-Cano MA, Respaldiza N, Alvarez A, Walter K, Franco E, Sanchez-Roman J, N&ntilde;&uacute;ez-Rold&aacute;n A. Clinical significance of anti-multiple nuclear dots\/Sp100 autoantibodies. Scand J Gastroenterol, <b>38<\/b>: 996-999, 2003.","DOI":"10.1080\/00365520310004876"},{"key":"19","doi-asserted-by":"crossref","unstructured":"21. Gao L, Tian X, Liu B, Zhang F. The value of antinuclear antibodies in primary biliary cirrhosis. Clin Exp Med, <b>8<\/b>: 9-15, 2008.","DOI":"10.1007\/s10238-008-0150-6"},{"key":"20","doi-asserted-by":"crossref","unstructured":"22. Worman HJ. Nuclear envelope protein autoantigens in primary biliary cirrhosis. Hepatol Res, <b>37<\/b> (Suppl 3): S406-411, 2007.","DOI":"10.1111\/j.1872-034X.2007.00227.x"},{"key":"21","unstructured":"23. Granito A, Muratori P, Muratori L, Pappas G, Cassani F, Worthington J, Ferri S, Quarneti C, Cipriano V, de Molo C, Lenzi M, Chapman RW, Bianchi FB. Antibodies to SS-A\/Ro-52kD and centromere in autoimmune liver disease: a clue to diagnosis and prognosis of primary biliary cirrhosis. Aliment Pharmacol Ther, <b>26<\/b>: 831-838, 2007."},{"key":"22","doi-asserted-by":"crossref","unstructured":"24. Chou MJ, Lee SL, Chen TY, Tsay GJ. Specificity of antinuclear antibodies in primary biliary cirrhosis. Ann Rheum Dis, <b>54<\/b>: 148-151, 1995.","DOI":"10.1136\/ard.54.2.148"},{"key":"23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2009.08.009"},{"key":"24","unstructured":"27. Tishler M, Alosachie I, Barka N, Lin HC, Gershwin ME, Peter JB, Shoenfeld Y. Primary Sj&ouml;gren's syndrome and primary biliary cirrhosis: differences and similarities in the autoantibody profile. Clin Exp Rheumatol, <b>13<\/b>: 497-500, 1995."},{"key":"25","doi-asserted-by":"crossref","unstructured":"28. Zeniya M, Watanabe F, Morizane T, Shibata M, Maeyama S, Kage M, Nakanuma Y, Toda G; Study Group of Intractable Liver Diseases for Research on a Specific Disease, Health Science Research Grant, Ministry of Health, Labour, and Welfare of Japan. Diagnosing clinical subsets of autoimmune liver diseases based on a multivariable model. J Gastroenterol, <b>40<\/b>: 1148-1154, 2005.","DOI":"10.1007\/s00535-005-1713-x"},{"key":"26","unstructured":"29. Tanaka A, Harada K, Ebinuma H, Komori A, Yokokawa J, Yoshizawa K, Abe M, Miyake Y, Kikuchi K, Ohira H, Zeniya M, Yamamoto K, Ishibashi H, Onji M, Nakanuma Y, Tsubouchi H, Takikawa H. Primary biliary cirrhosis&mdash;Autoimmune hepatitis overlap syndrome: A rationale for corticosteroids use based on a nation-wide retrospective study in Japan. Hepatol Res, <b>41<\/b>: 877-886, 2011."},{"key":"27","doi-asserted-by":"crossref","unstructured":"31. Courvalin JC, Lassoued K, Bartnik E, Bartnik E, Blobel G, Wozniak RW. The 210-kD nuclear envelope polypeptide recognized by human autoantibodies in primary biliary cirrhosis is the major glycoprotein of the nuclear pore. J Clin Invest, <b>86<\/b>: 279-285, 1990.","DOI":"10.1172\/JCI114696"},{"key":"28","doi-asserted-by":"crossref","unstructured":"32. Muratori P, Muratori L, Ferrari R, Cassani F, Bianchi G, Lenzi M, Rodrigo L, Linares A, Fuentes D, Bianchi FB. Characterization and clinical impact of antinuclear antibodies in primary biliary cirrhosis. Am J Gastroenterol, <b>98<\/b>: 431-437, 2003.","DOI":"10.1111\/j.1572-0241.2003.07257.x"},{"key":"29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2004.11.016"},{"key":"30","doi-asserted-by":"crossref","unstructured":"34. Nakamura M, Komori A, Ito M, Kondo H, Aiba Y, Migita K, Nagaoka S, Ohata K, Yano K, Abiru S, Daikoku M, Yatsuhashi H, Shimoda S, Ishibashi H. Predictive role of anti-gp210 and anticentromere antibodies in long-term outcome of primary biliary cirrhosis. Hepatol Res, <b>37<\/b>(Suppl 3): S412-419, 2007.","DOI":"10.1111\/j.1872-034X.2007.00244.x"},{"key":"31","doi-asserted-by":"crossref","unstructured":"35. Nakamura M, Takii Y, Ito M, Komori A, Yokoyama T, Shimizu-Yoshida Y, Koyabu M, Matsuyama M, Mori T, Kamihira T, Daikoku M, Migita K, Yatsuhashi H, Nozaki N, Shimoda S, Ishibashi H. Increased expression of nuclear envelope gp210 antigen in small bile ducts in primary biliary cirrhosis. J Autoimmun, <b>26<\/b>: 138-145, 2006","DOI":"10.1016\/j.jaut.2005.10.007"},{"key":"32","doi-asserted-by":"crossref","unstructured":"36. Schulte-Pelkum J, Fritzler M, Mahler M. Latest update on the Ro\/SS-A autoantibody system. Autoimmun Rev, <b>8<\/b>: 632-637, 2009.","DOI":"10.1016\/j.autrev.2009.02.010"},{"key":"33","doi-asserted-by":"publisher","DOI":"10.1007\/BF00328227"},{"key":"34","doi-asserted-by":"crossref","unstructured":"38. Ahmed SS, Tan FK, Arnett FC, Jin L, Geng YJ. Induction of apoptosis and fibrillin 1 expression in human dermal endothelial cells by scleroderma sera containing anti-endothelial cell antibodies. Arthritis Rheum, <b>54<\/b>: 2250-2262, 2006.","DOI":"10.1002\/art.21952"},{"key":"35","doi-asserted-by":"crossref","unstructured":"39. Pawlotsky JM, Andre C, Metreau JM, Beaugrand M, Zafrani ES, Dhumeaux D. Multiple nuclear dots antinuclear antibodies are not specific for primary biliary cirrhosis. Hepatology, <b>16<\/b>: 127-131, 1992.","DOI":"10.1002\/hep.1840160121"},{"key":"36","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3083.1995.tb03652.x"}],"container-title":["FUKUSHIMA JOURNAL OF MEDICAL SCIENCE"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,6,27]],"date-time":"2023-06-27T20:18:57Z","timestamp":1687897137000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/fms\/58\/2\/58_107\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.5387\/fms.58.107","relation":{},"ISSN":["0016-2590","2185-4610"],"issn-type":[{"value":"0016-2590","type":"print"},{"value":"2185-4610","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012]]}}}